Skip to main content

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Prevalencia de las quasispecies mutantes en antígeno de superficie en paceintes con hepatitis crónica B y trasplantados por hepatitis B

IP: Maria Buti Ferret
Collaborators: Andrea Caballero Garralda, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 275715.44
Reference: PI11/01973
Duration: 01/01/2012 - 28/02/2015

Análisis de la cuasispecie viral en la infección por virus de la hepatitis B: evolución natural yu asociada al tratamiento antiviral

IP: -
Collaborators: Maria Buti Ferret, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 90750
Reference: PI09/00899
Duration: 01/01/2010 - 31/12/2012

Caracterización de perfiles proteómicos predictivos de hepatotoxicidad asociada a medicamentos antituberculosos: un estudio exploratorio

IP: -
Collaborators: Jaume Reventós Puigjaner, Francesc Canals Suris, Maria Buti Ferret, Xavier Martínez Gómez, Teresa Soriano Sánchez, Israel Molina Romero, Eulàlia Pérez Esquirol, Mònica Sabaté Gallego, Maria Urquizu Padilla, Núria Colome Calls
Funding agency: Instituto de Salud Carlos III
Funding: 150645
Reference: EC08/00250
Duration: 01/01/2009 - 31/12/2012

Unitat de Recerca en Malalties Hepatobiliars

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Antonio González Fernández, Lluis Castells Fusté, Silvia Sauleda Oliveras, Lluís Palenzuela Díaz, Maria Buti Ferret, Josep Quer Sivila, Unitat de Recerca en Malalties Hepatobiliars, Juan Ignacio Esteban Mur, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 54080
Reference: 2009 SGR 383
Duration: 01/01/2010 - 30/04/2014

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

This tool will help avoid invasive techniques and assist in selecting candidates for clinical trials of new treatments.

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

Related professionals

Marc Simo Perdigo

Marc Simo Perdigo

Molecular Imaging and Therapy
Read more
Richard Miguel Lomas Albuja

Richard Miguel Lomas Albuja

Ethics Committees Support Unit (USCE)
External Strategy Directorate
Read more
Joaquim Sola  Santesmases

Joaquim Sola Santesmases

General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Katerina Papadakis

Katerina Papadakis

Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.